Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
Christine LundgrenPär-Ola BendahlMaria EkholmMårten FernöCarina ForsareUte KrügerBo NordenskjöldOlle StålLisa RydénPublished in: Breast cancer research : BCR (2020)
This trial is registered in the ISRCTN database, trial ID: ISRCTN12474687 .